MedPath

Felodipine

Generic Name
Felodipine
Brand Names
Plendil
Drug Type
Small Molecule
Chemical Formula
C18H19Cl2NO4
CAS Number
72509-76-3
Unique Ingredient Identifier
OL961R6O2C

Overview

Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.

Background

Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.

Indication

For the treatment of mild to moderate essential hypertension.

Associated Conditions

  • Hypertension

FDA Approved Products

Felodipine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:10 mg in 1 1
Approved: 2021/05/21
NDC:63629-2016
Felodipine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2024/02/02
NDC:72162-1742
Felodipine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:5 mg in 1 1
Approved: 2024/02/17
NDC:71335-1318
Felodipine
Manufacturer:Rising Pharma Holdings, Inc.
Route:ORAL
Strength:10 mg in 1 1
Approved: 2024/02/17
NDC:57237-110
Felodipine
Manufacturer:Westminster Pharmaceuticals, LLC
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2023/04/04
NDC:69367-264

Singapore Approved Products

PLENDIL TABLET 5 mg
Manufacturer:ASTRAZENECA AB, ASTRAZENECA PTY LTD, AstraZeneca Pharmaceutical Co. Ltd
Form:TABLET, EXTENDED RELEASE
Strength:5 mg
Online:Yes
Approved: 1996/07/03
Approval:SIN08781P
PLENDIL TABLET 10 mg
Manufacturer:ASTRAZENECA AB, ASTRAZENECA PTY LTD, AstraZeneca Pharmaceutical Co. Ltd
Form:TABLET, EXTENDED RELEASE
Strength:10 mg
Online:Yes
Approved: 1996/07/03
Approval:SIN08768P
PLENDIL TABLET 2.5 mg
Manufacturer:ASTRAZENECA AB, ASTRAZENECA PTY LTD, AstraZeneca Pharmaceutical Co. Ltd
Form:TABLET, EXTENDED RELEASE
Strength:2.5 mg
Online:Yes
Approved: 1994/06/15
Approval:SIN07738P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath